9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Pfizer
Adela, Inc
Massive Bio, Inc.
Incyte Corporation
Trishula Therapeutics, Inc.
Tempus AI
Intensity Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
Taproot Health
VitaMed Research LLC
Sanguine Biosciences
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
ImmVira Pharma Co. Ltd
Blue Note Therapeutics
Incyte Corporation
Celgene
LEO Pharma
Shenzhen BinDeBio Ltd.
Amgen
Sandoz
Valerio Therapeutics
Philogen S.p.A.
Altor BioScience
Novartis
Amgen
Amgen